APA (7th ed.) Citation

Yan, L., Huo, P., Debenham, J. S., Madsen-Duggan, C. B., Lao, J., Chen, R. Z., . . . Hale, J. J. (2010). Discovery of N-[(4R)-6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist for the Treatment of Obesity. Journal of medicinal chemistry, 53(10), 4028-4037. https://doi.org/10.1021/jm100023j

Chicago Style (17th ed.) Citation

Yan, Lin, et al. "Discovery of N-[(4R)-6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist for the Treatment of Obesity." Journal of Medicinal Chemistry 53, no. 10 (2010): 4028-4037. https://doi.org/10.1021/jm100023j.

MLA (9th ed.) Citation

Yan, Lin, et al. "Discovery of N-[(4R)-6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist for the Treatment of Obesity." Journal of Medicinal Chemistry, vol. 53, no. 10, 2010, pp. 4028-4037, https://doi.org/10.1021/jm100023j.